Dendritic cells revisited in human allergic rhinitis and asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 2, 2016, Pages 137-148

  Froidure, A ^a,b   Shen, C ^a   Pilette, C ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

allergic inflammation; Asthma; bronchial epithelium; dendritic cells

Indexed keywords

CORTICOSTEROID; FC RECEPTOR; HOST FACTOR; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; ALLERGEN; IMMUNOGLOBULIN; TOLL LIKE RECEPTOR;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SURFACE; DENDRITIC CELL; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IMMUNOTHERAPY; INFLAMMATION; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEADY STATE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; ASTHMA; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MUCOSA; PHENOTYPE; RHINITIS, ALLERGIC; TH2 CELL;

ALLERGENS; ANIMALS; ASTHMA; DENDRITIC CELLS; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; MUCOUS MEMBRANE; PHENOTYPE; RECEPTORS, FC; RHINITIS, ALLERGIC; TH2 CELLS; TOLL-LIKE RECEPTORS;

EID: 84955339327     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12770     Document Type: Review

References (133)

1. Lambrecht BN, Hammad H,. Biology of lung dendritic cells at the origin of asthma. Immunity 2009; 31: 412-424.
2. Taube C, Dakhama A, Gelfand EW,. Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allergy Immunol 2004; 135: 173-186.
3. Holmes AM, Solari R, Holgate ST,. Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov Today 2011; 16: 659-670.
4. Crozat K, Guiton R, Guilliams M, Henri S, Baranek T, Schwartz-Cornil I, et al., Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunol Rev 2010; 234: 177-198.
5. Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco-Madeira F, Toussaint W, et al., Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013; 38: 322-335.
6. Lambrecht BN, Hammad H,. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu Rev Immunol 2012; 30: 243-270.
7. Kushwah R, Hu J,. Complexity of dendritic cell subsets and their function in the host immune system. Immunology 2011; 133: 409-419.
8. de Heer HJ, Hammad H, Soullie T, Hijdra D, Vos N, Willart MA, et al., Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004; 200: 89-98.
9. Matta BM, Castellaneta A, Thomson AW,. Tolerogenic plasmacytoid DC. Eur J Immunol 2010; 40: 2667-2676.
10. Kool M, van Nimwegen M, Willart MA, Muskens F, Boon L, Smit JJ, et al., An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation. J Immunol 2009; 183: 1074-1082.
11. Ito T, Amakawa R, Inaba M, Hori T, Ota M, Nakamura K, et al., Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs. J Immunol 2004; 172: 4253-4259.
12. Kassner N, Krueger M, Yagita H, Dzionek A, Hutloff A, Kroczek R, et al., Cutting edge: Plasmacytoid dendritic cells induce IL-10 production in T cells via the Delta-like-4/Notch axis. J Immunol 2010; 184: 550-554.
13. Wythe SE, Dodd JS, Openshaw PJ, Schwarze J,. OX40 ligand and programmed cell death 1 ligand 2 expression on inflammatory dendritic cells regulates CD4 T cell cytokine production in the lung during viral disease. J Immunol 2012; 188: 1647-1655.
14. Greter M, Helft J, Chow A, Hashimoto D, Mortha A, Agudo-Cantero J, et al., GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 2012; 36: 1031-1046.
15. Hammad H, Plantinga M, Deswarte K, Pouliot P, Willart MA, Kool M, et al., Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 2010; 207: 2097-2111.
16. Segura E, Touzot M, Bohineust A, Cappuccio A, Chiocchia G, Hosmalin A, et al., Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013; 38: 336-348.
17. Demedts IK, Brusselle GG, Vermaelen KY, Pauwels RA,. Identification and characterization of human pulmonary dendritic cells. Am J Respir Cell Mol Biol 2005; 32: 177-184.
18. Demedts IK, Bracke KR, Maes T, Joos GF, Brusselle GG,. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. Am J Respir Cell Mol Biol 2006; 35: 387-393.
19. Andersson LI, Cirkic E, Hellman P, Eriksson H,. Myeloid blood dendritic cells and monocyte-derived dendritic cells differ in their endocytosing capability. Hum Immunol 2012; 73: 1073-1081.
20. Novak N, Allam JP, Betten H, Haberstok J, Bieber T,. The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy 2004; 59: 5-14.
21. Lambrecht BN, Hammad H,. The airway epithelium in asthma. Nat Med 2012; 18: 684-692.
22. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN,. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15: 410-416.
23. Willart MA, Deswarte K, Pouliot P, Braun H, Beyaert R, Lambrecht BN, et al., Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 2012; 209: 1505-1517.
24. Eiwegger T, Akdis CA,. IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur J Immunol 2011; 41: 1535-1538.
25. Kool M, Willart MA, van Nimwegen M, Bergen I, Pouliot P, Virchow JC, et al., An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 2011; 34: 527-540.
26. Angkasekwinai P, Park H, Wang YH, Wang YH, Chang SH, Corry DB, et al., Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-1517.
27. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, et al., TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005; 202: 1213-1223.
28. Kawai T, Akira S,. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-650.
29. Janeway CA Jr,. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54: 1-13.
30. Allavena P, Chieppa M, Monti P, Piemonti L,. From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit Rev Immunol 2004; 24: 179-192.
31. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, et al., Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457: 585-588.
32. Hammad H, Charbonnier AS, Duez C, Jacquet A, Stewart GA, Tonnel AB, et al., Th2 polarization by Der p 1-pulsed monocyte-derived dendritic cells is due to the allergic status of the donors. Blood 2001; 98: 1135-1141.
33. Huang HJ, Lin YL, Liu CF, Kao HF, Wang JY,. Mite allergen decreases DC-SIGN expression and modulates human dendritic cell differentiation and function in allergic asthma. Mucosal Immunol 2011; 4: 519-527.
34. Nakano H, Free ME, Whitehead GS, Maruoka S, Wilson RH, Nakano K, et al., Pulmonary CD103(+) dendritic cells prime Th2 responses to inhaled allergens. Mucosal Immunol 2012; 5: 53-65.
35. Clarke DL, Davis NH, Campion CL, Foster ML, Heasman SC, Lewis AR, et al., Dectin-2 sensing of house dust mite is critical for the initiation of airway inflammation. Mucosal Immunol 2014; 7: 558-567.
36. Emara M, Royer PJ, Mahdavi J, Shakib F, Ghaemmaghami AM,. Retagging identifies dendritic cell-specific intercellular adhesion molecule-3 (ICAM3)-grabbing non-integrin (DC-SIGN) protein as a novel receptor for a major allergen from house dust mite. J Biol Chem 2012; 287: 5756-5763.
37. Salazar F, Ghaemmaghami AM,. Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells. Front Immunol 2013; 4: 356.
38. Hasan AA, Ghaemmaghami AM, Fairclough L, Robins A, Sewell HF, Shakib F,. Allergen-driven suppression of thiol production by human dendritic cells and the effect of thiols on T cell function. Immunobiology 2009; 214: 2-16.
39. Horlock C, Shakib F, Jones NS, Sewell HF, Ghaemmaghami AM,. Differential protein expression by dendritic cells from atopic and non-atopic individuals after stimulation by the major house dust mite allergen Der p 1. Int Arch Allergy Immunol 2009; 150: 237-251.
40. Lewkowich IP, Day SB, Ledford JR, Zhou P, Dienger K, Wills-Karp M, et al., Protease-activated receptor 2 activation of myeloid dendritic cells regulates allergic airway inflammation. Respir Res 2011; 12: 122.
41. Mishra A, Brown AL, Yao X, Yang S, Park SJ, Liu C, et al., Dendritic cells induce Th2-mediated airway inflammatory responses to house dust mite via DNA-dependent protein kinase. Nat Commun 2015; 6: 6224.
42. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J,. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001; 167: 5067-5076.
43. Re F, Strominger JL,. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276: 37692-37699.
44. Edwards AD, Manickasingham SP, Sporri R, Diebold SS, Schulz O, Sher A, et al., Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J Immunol 2002; 169: 3652-3660.
45. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al., Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347: 869-877.
46. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159-166.
47. Kearney SC, Dziekiewicz M, Feleszko W,. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma. Ann Allergy Asthma Immunol 2015; 114: 364-369.
48. Huang YJ, Boushey HA,. The microbiome in asthma. J Allergy Clin Immunol 2015; 135: 25-30.
49. McWilliam AS, Marsh AM, Holt PG,. Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: involvement of epithelial dendritic cells. J Virol 1997; 71: 226-236.
50. Subrata LS, Bizzintino J, Mamessier E, Bosco A, McKenna KL, Wikstrom ME, et al., Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol 2009; 183: 2793-2800.
51. Holt PG, Sly PD,. Interaction between adaptive and innate immune pathways in the pathogenesis of atopic asthma: operation of a lung/bone marrow axis. Chest 2011; 139: 1165-1171.
52. Maurer D, Fiebiger S, Ebner C, Reininger B, Fischer GF, Wichlas S, et al., Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996; 157: 607-616.
53. Novak N, Allam JP,. Mucosal dendritic cells in allergy and immunotherapy. Allergy 2011; 66 (Suppl. 95): 22-24.
54. Klinman DM, Steinberg AD,. Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 1987; 165: 1755-1760.
55. Smith KG, Clatworthy MR,. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 2010; 10: 328-343.
56. Nimmerjahn F, Ravetch JV,. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; 8: 34-47.
57. Nimmerjahn F, Ravetch JV,. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 2008; 26: 513-533.
58. von Gunten S, Shoenfeld Y, Blank M, Branch DR, Vassilev T, Kasermann F, et al., IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. Nat Rev Immunol 2014; 14: 349.
59. Maddur MS, Vani J, Hegde P, Lacroix-Desmazes S, Kaveri SV, Bayry J,. Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. J Allergy Clin Immunol 2011; 127: 823-830.
60. Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, et al., Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 2003; 101: 758-765.
61. Anthony RM, Kobayashi T, Wermeling F, Ravetch JV,. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 2011; 475: 110-113.
62. Zhou Y, Kawasaki H, Hsu SC, Lee RT, Yao X, Plunkett B, et al., Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat Med 2010; 16: 1128-1133.
63. Massoud AH, Yona M, Xue D, Chouiali F, Alturaihi H, Ablona A, et al., Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. J Allergy Clin Immunol 2014; 133: 853-863.
64. Macpherson AJ, Geuking MB, McCoy KD,. Immunoglobulin A: a bridge between innate and adaptive immunity. Curr Opin Gastroenterol 2011; 27: 529-533.
65. Monteiro RC, Van De Winkel JG,. IgA Fc receptors. Annu Rev Immunol 2003; 21: 177-204.
66. Pasquier B, Launay P, Kanamaru Y, Moura IC, Pfirsch S, Ruffie C, et al., Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005; 22: 31-42.
67. Kanamaru Y, Pfirsch S, Aloulou M, Vrtovsnik F, Essig M, Loirat C, et al., Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation. J Immunol 2008; 180: 2669-2678.
68. Cerutti A, Rescigno M,. The biology of intestinal immunoglobulin A responses. Immunity 2008; 28: 740-750.
69. Diana J, Moura IC, Vaugier C, Gestin A, Tissandie E, Beaudoin L, et al., Secretory IgA induces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice. J Immunol 2013; 191: 2335-2343.
70. Pilette C, Nouri-Aria KT, Jacobson MR, Wilcock LK, Detry B, Walker SM, et al., Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J Immunol 2007; 178: 4658-4666.
71. Pilette C, Detry B, Guisset A, Gabriels J, Sibille Y,. Induction of interleukin-10 expression through Fcalpha receptor in human monocytes and monocyte-derived dendritic cells: role of p38 MAPKinase. Immunol Cell Biol 2010; 88: 486-493.
72. Smits HH, Gloudemans AK, van Nimwegen M, Willart MA, Soullie T, Muskens F, et al., Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol 2009; 2: 331-339.
73. Lecocq M, Detry B, Guisset A, Pilette C,. FcalphaRI-mediated inhibition of IL-12 production and priming by IFN-gamma of human monocytes and dendritic cells. J Immunol 2013; 190: 2362-2371.
74. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA,. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106: 551-559.
75. Hammad H, Lambrecht BN, Pochard P, Gosset P, Marquillies P, Tonnel AB, et al., Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J Immunol 2002; 169: 1524-1534.
76. van Rijt LS, Jung S, Kleinjan A, Vos N, Willart M, Duez C, et al., In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005; 201: 981-991.
77. Farrell E, O'Connor TM, Duong M, Watson RM, Strinich T, Gauvreau GM, et al., Circulating myeloid and plasmacytoid dendritic cells after allergen inhalation in asthmatic subjects. Allergy 2007; 62: 1139-1145.
78. Matsuda H, Suda T, Hashizume H, Yokomura K, Asada K, Suzuki K, et al., Alteration of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma. Am J Respir Crit Care Med 2002; 166: 1050-1054.
79. Dua B, Watson RM, Gauvreau GM, O'Byrne PM,. Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J Allergy Clin Immunol 2010; 126: 133-139.
80. Bratke K, Lommatzsch M, Julius P, Kuepper M, Kleine HD, Luttmann W, et al., Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax 2007; 62: 168-175.
81. Upham JW, Denburg JA, O'Byrne PM,. Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy 2002; 32: 818-823.
82. Greer AM, Matthay MA, Kukreja J, Bhakta NR, Nguyen CP, Wolters PJ, et al., Accumulation of BDCA1+ Dendritic Cells in Interstitial Fibrotic Lung Diseases and Th2-High Asthma. PLoS ONE 2014; 9: e99084.
83. Kayserova J, Zentsova-Jaresova I, Budinsky V, Rozkova D, Kopecka J, Vernerova E, et al., Selective increase in blood dendritic cell antigen-3-positive dendritic cells in bronchoalveolar lavage fluid in allergic patients. Scand J Immunol 2012; 75: 305-313.
84. Dua B, Smith S, Kinoshita T, Imaoka H, Gauvreau G, O'Byrne P,. Myeloid dendritic cells type 2 in allergic asthma. Allergy 2013; 68: 1322-1326.
85. Martikainen MV, Kaario H, Karvonen A, Schroder PC, Renz H, Kaulek V, et al., Farm exposures are associated with lower percentage of circulating myeloid dendritic cell subtype 2 at age 6. Allergy 2015; 70: 1278-1287.
86. Holloway JA, Holgate ST, Semper AE,. Expression of the high-affinity IgE receptor on peripheral blood dendritic cells: differential binding of IgE in atopic asthma. J Allergy Clin Immunol 2001; 107: 1009-1018.
87. Foster B, Metcalfe DD, Prussin C,. Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma. J Allergy Clin Immunol 2003; 112: 1132-1138.
88. Kraft S, Wessendorf JH, Hanau D, Bieber T,. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J Immunol 1998; 161: 1000-1006.
89. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, et al., The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol 1995; 154: 6285-6290.
90. Bieber T,. The pro- and anti-inflammatory properties of human antigen-presenting cells expressing the high affinity receptor for IgE (Fc epsilon RI). Immunobiology 2007; 212: 499-503.
91. Dhaliwal B, Yuan D, Pang MO, Henry AJ, Cain K, Oxbrow A, et al., Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor FcepsilonRI. Proc Natl Acad Sci U S A 2012; 109: 12686-12691.
92. Greer AM, Wu N, Putnam AL, Woodruff PG, Wolters P, Kinet JP, et al., Serum IgE clearance is facilitated by human FcepsilonRI internalization. J Clin Invest 2014; 124: 1187-1198.
93. Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM,. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 1993; 178: 1753-1763.
94. Chelen CJ, Fang Y, Freeman GJ, Secrist H, Marshall JD, Hwang PT, et al., Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995; 95: 1415-1421.
95. Greenwald RJ, Freeman GJ, Sharpe AH,. The B7 family revisited. Annu Rev Immunol 2005; 23: 515-548.
96. Singh AK, Stock P, Akbari O,. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 2011; 66: 155-162.
97. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, et al., T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402: 827-832.
98. Botturi K, Lacoeuille Y, Cavailles A, Vervloet D, Magnan A,. Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4. Respir Res 2011; 12: 25.
99. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, et al., Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8: 1024-1032.
100. Ito T, Yang M, Wang YH, Lande R, Gregorio J, Perng OA, et al., Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 2007; 204: 105-115.
101. Shen C, Hupin C, Froidure A, Detry B, Pilette C,. Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma. Clin Exp Allergy 2014; 44: 831-841.
102. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, et al., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009; 206: 3015-3029.
103. Froidure A, Vandenplas O, D'Alpaos V, Evrard G, Pilette C,. Persistence of asthma following allergen avoidance is associated with proTh2 myeloid dendritic cell activation. Thorax 2015; 70: 967-973.
104. Hammad H, Lambrecht BN,. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008; 8: 193-204.
105. Froidure A, Shen C, Gras D, Van Snick J, Chanez P, Pilette C,. Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy 2014; 69: 1068-1076.
106. Matthews NC, Pfeffer PE, Mann EH, Kelly FJ, Corrigan CJ, Hawrylowicz CM, et al., Urban Particulate Matter-activated Human Dendritic Cells Induce the Expansion of Potent Inflammatory Th1, Th2 and Th17 Effector Cells. Am J Respir Cell Mol Biol 2015; DOI: 10.1165/rcmb.2015-0084OC.
107. Bratke K, Prieschenk C, Garbe K, Kuepper M, Lommatzsch M, Virchow JC,. Plasmacytoid dendritic cells in allergic asthma and the role of inhaled corticosteroid treatment. Clin Exp Allergy 2013; 43: 312-321.
108. Pilette C, Jacobson MR, Ratajczak C, Detry B, Banfield G, VanSnick J, et al., Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis. Allergy 2013; 68: 312-321.
109. Lebre MC, van CT, Bos JD, Knol EF, Kapsenberg ML, de Jong EC,. Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients. J Allergy Clin Immunol 2008; 122: 969-976.
110. Tversky JR, Le TV, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT,. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin Exp Allergy 2008; 38: 781-788.
111. Le T, Tversky J, Chichester KL, Bieneman AP, Huang SK, Wood RA, et al., Interferons modulate Fc epsilon RI-dependent production of autoregulatory IL-10 by circulating human monocytoid dendritic cells. J Allergy Clin Immunol 2009; 123: 217-223.
112. Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, et al., Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011; 364: 1005-1015.
113. Ferreira MA, Matheson MC, Duffy DL, Marks GB, Hui J, Le Souef P, et al., Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet 2011; 378: 1006-1014.
114. Barnes PJ,. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 1998; 102: 531-538.
115. Umland SP, Schleimer RP, Johnston SL,. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Ther 2002; 15: 35-50.
116. Georas SN,. Inhaled glucocorticoids, lymphocytes, and dendritic cells in asthma and obstructive lung diseases. Proc Am Thorac Soc 2004; 1: 215-221.
117. Moller GM, Overbeek SE, Van Helden-Meeuwsen CG, Van Haarst JM, Prens EP, Mulder PG, et al., Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996; 26: 517-524.
118. Hamdi H, Godot V, Maillot MC, Prejean MV, Cohen N, Krzysiek R, et al., Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 2007; 110: 211-219.
119. Krzysiek R,. Role of glucocorticoid-induced leucine zipper (GILZ) expression by dendritic cells in tolerance induction. Transplant Proc 2010; 42: 3331-3332.
120. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, et al., Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108: 184-190.
121. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, et al., Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005; 60: 309-316.
122. Prussin C, Griffith DT, Boesel KM, Lin H, Foster B, Casale TB,. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol 2003; 112: 1147-1154.
123. Chanez P, Contin-Bordes C, Garcia G, Verkindre C, Didier A, De Blay F, et al., Omalizumab-induced decrease of FcxiRI expression in patients with severe allergic asthma. Respir Med 2010; 104: 1608-1617.
124. Schroeder JT, Bieneman AP, Chichester KL, Hamilton RG, Xiao H, Saini SS, et al., Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization. J Allergy Clin Immunol 2010; 125: 896-901.
125. Allam JP, Peng WM, Appel T, Wenghoefer M, Niederhagen B, Bieber T, et al., Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 2008; 121: 368-374.
126. Wu Z,. Antigen specific immunotherapy generates CD27(+) CD35(+) tolerogenic dendritic cells. Cell Immunol 2013; 283: 75-80.
127. Larche M, Akdis CA, Valenta R,. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6: 761-771.
128. Dreschler K, Bratke K, Petermann S, Bier A, Thamm P, Kuepper M, et al., Impact of immunotherapy on blood dendritic cells in patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2011; 127: 487-494.
129. Zhang F, Huang G, Hu B, Song Y, Shi Y,. A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells. Clin Exp Immunol 2011; 164: 256-264.
130. Chen ZG, Zhang TT, Li HT, Chen FH, Zou XL, Ji JZ, et al., Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PLoS ONE 2013; 8: e51268.
131. Cheng DT, Ma C, Niewoehner J, Dahl M, Tsai A, Zhang J, et al., Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. J Allergy Clin Immunol 2013; 132: 455-462.
132. Lee HY, Rhee CK, Kang JY, Byun JH, Choi JY, Kim SJ, et al., Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res 2014; 40: 66-76.
133. Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, et al., Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 2014; 370: 2102-2110.